Official Statements Archives

May 21, 2024

CLL Society’s Official Statement on Mask Wearing and Other Protective Measures for Those Living with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL / SLL) in Healthcare Settings

CLL Society has created our Statement on Mask Wearing and Other Protective Measures for Those Living with CLL to protect against respiratory infections spread.

February 6, 2023

CLL Society’s Official Statement Regarding Workplace Accommodations for People with CLL / SLL While There is Risk of COVID-19 Exposure (Update 2/6/2023)

As the risk of COVID-19 exposure stretches on, we have updated our official statement concerning working conditions for people with CLL / SLL (Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma) that you can download for your own reference and to share with the appropriate people in your life including HR and co-workers.

September 20, 2022

New Mechanism for Small Medical Practices to Order One or Two Doses of Evusheld

There is a new option for easy access for those with CLL / SLL who are seeking Evusheld. Regardless of their specialty, your healthcare provider can order it directly for only one or two patients.

April 8, 2022

CLL Society’s Official Statement on Evusheld, Boosters, and COVID-19 Therapies

CLL Society has put together a letter that you can print out and take with you, whether it be to a pharmacy, health department, or even your physician, to help reinforce the recommended guidance and clarify your need as an immunocompromised person with CLL / SLL.

February 17, 2022

AstraZeneca to Supply the US Government with an Additional One Million Doses of EVUSHELD Long-Acting Antibody Combination for the Prevention of COVID-19

EVUSHELD is in short supply. And to put it politely, distribution has been inequitable.

July 21, 2021

CLL Society’s Recommendations for COVID-19 Vaccinated Chronic Lymphocytic Leukemia (CLL) Patients-Based Upon the CDC’s Updated Considerations for People Who Are Immunocompromised and Other Underlying Data

CLL patients should be vaccinated against COVID-19 as some protection is better than none. CLL patients should not assume that because they are vaccinated that they are protected. We recommend that even fully vaccinated CLL patients follow CDC guidelines for the unvaccinated including: Wearing a well-fitting (preferably N95) mask indoor and in

April 6, 2021

Explaining to Family and Friends Why the General CDC Guidelines for Those Vaccinated Against COVID-19 Do Not Apply to Chronic Lymphocytic Leukemia Patients

The world is opening back up. Although we may have been moved near the front of the line to be vaccinated, those of us with CLL even after being vaccinated are going to be among the last to join the celebratory parades, concerts, restaurants, and even intimate dinners at

March 11, 2021

Interim Public Health Recommendations for People Fully Vaccinated Against COVID-19: What They Mean for the Chronic Lymphocytic Leukemia (CLL) Population

Interim Public Health Recommendations for People Fully Vaccinate against COVID-19: What They Mean for the Chronic Lymphocytic Leukemia (CLL) Population

January 4, 2021

CLL Society’s Official Statement Concerning SARS-CoV-2 Vaccine in CLL Patients

Updated: 3/26/2021 We have heard your questions! Should I get the vaccine? Is it safe? Which vaccine? What are the side effects? Can I get COVID from the shots? Where should CLL patients be in line to be vaccinated? CLL Society provides the current best answers to these and

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Official Statements

CLL Society’s Official Statement on Mask Wearing and Other Protective Measures for Those Living with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL / SLL) in Healthcare Settings

CLL Society’s Official Statement Regarding Workplace Accommodations for People with CLL / SLL While There is Risk of COVID-19 Exposure (Update 2/6/2023)

New Mechanism for Small Medical Practices to Order One or Two Doses of Evusheld

CLL Society’s Official Statement on Evusheld, Boosters, and COVID-19 Therapies

AstraZeneca to Supply the US Government with an Additional One Million Doses of EVUSHELD Long-Acting Antibody Combination for the Prevention of COVID-19

CLL Society’s Recommendations for COVID-19 Vaccinated Chronic Lymphocytic Leukemia (CLL) Patients-Based Upon the CDC’s Updated Considerations for People Who Are Immunocompromised and Other Underlying Data

Explaining to Family and Friends Why the General CDC Guidelines for Those Vaccinated Against COVID-19 Do Not Apply to Chronic Lymphocytic Leukemia Patients

Interim Public Health Recommendations for People Fully Vaccinated Against COVID-19: What They Mean for the Chronic Lymphocytic Leukemia (CLL) Population

CLL Society’s Official Statement Concerning SARS-CoV-2 Vaccine in CLL Patients

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT CLL SOCIETY

CONTACT